Chorioptes Bovis (Cattle Leg Mite): Livestock Mange, Not Human Allergy

Yes, but extremely rarely. The published medical literature contains only a handful of case reports of transient C. bovis transfer to humans, all involving farm workers with prolonged direct skin contact with heavily infested cattle legs. In each documented case, reactions were mild and self-limiting, resolving within weeks once the infested animals were treated or contact was reduced. C. bovis cannot establish a persistent infestation on human skin — it is adapted to livestock hosts and its lifecycle cannot be completed on human tissue. The risk is so low that it does not warrant specific medical prophylaxis.

Early chorioptic mange in cattle presents as hair loss and mild scaling on the lower legs, tailhead, and perineum — areas with least fleece or hair coverage. As infestation progresses, affected skin becomes thickened, wrinkled, and crusted, with intense pruritus causing cattle to stamp their feet, rub legs together, and chew at affected areas. In severe cases, the skin surface develops a rough, warty, crusty appearance. Secondary bacterial infection produces a wet, malodorous discharge. Scrotal mange in rams causes severe swelling and scaling of the scrotum. The pattern of lower leg involvement distinguishes chorioptic from sarcoptic (generalized) or psoroptic (body and ear) mange.

No — chorioptic mange (C. bovis) and sarcoptic mange (Sarcoptes scabiei bovis) are caused by different mites with different biologies and clinical presentations. Sarcoptes burrows into the skin, causing intense generalized pruritus over the neck, shoulder, and flank as well as the legs. Chorioptes feeds on the skin surface and concentrates on the lower extremities. Sarcoptic mange in cattle is more severe, spreads more rapidly, and can cause significant weight loss. Critically, Sarcoptes scabiei can cause genuine scabies in humans (an important occupational hazard for cattle farmers), while C. bovis essentially cannot establish human infestation. Differential diagnosis between the two in livestock requires microscopic examination of skin scrapings.

Macrocyclic lactones are the first-line treatment — injectable ivermectin or moxidectin and pour-on formulations are both effective. A single treatment achieves significant mite burden reduction, but a second treatment 2-3 weeks later is recommended to target mites that were in egg stage during the first treatment (macrocyclic lactones do not reliably kill eggs). All animals in a group should be treated simultaneously. Severely affected skin lesions benefit from topical acaricidal treatment and gentle removal of crusts to improve drug penetration. Animals should be monitored 4-6 weeks after treatment to confirm efficacy and detect treatment failures before the next housing season.

A medical consultation is appropriate if your skin symptoms are severe, worsening, or not improving after 2-3 weeks without animal contact. In most cases, transient pruritic papules from C. bovis contact are mild enough to manage at home with over-the-counter topical hydrocortisone cream and oral antihistamines for itch. If you develop signs of secondary bacterial skin infection — spreading redness, warmth, pus, or fever — see a doctor promptly for antibiotic assessment. If respiratory symptoms accompany the skin reaction, consider occupational allergy evaluation rather than attributing the symptoms to C. bovis.

Yes — cross-host infestation between cattle and horses with Chorioptes bovis and its host-adapted variants has been documented. C. bovis var. equi is the horse-specific variant, but cattle and equine mite variants can infest each other transiently. In mixed-species operations where cattle and horses share paddocks, handling equipment, or bedding, mite cross-contamination is possible. Treating both species simultaneously and cleaning shared handling equipment reduces cross-infestation risk. Horses with lower leg pruritus, scaling, and stamping behavior should be examined for chorioptic mange alongside routine veterinary assessment.

Three main mange mites affect sheep: Chorioptes bovis var. ovis (leg/scrotal mange), Psoroptes ovis (body mange, sheep scab — a notifiable disease), and Sarcoptes scabiei var. ovis (head mange). Chorioptic mange concentrates on the lower legs, feet, and scrotum of rams, typically causing less severe disease than the other types. Psoroptic mange (sheep scab) causes intensely pruritic body lesions beginning on the back and shoulders, spreading rapidly to cover the whole body — this is a notifiable disease in the UK and EU. Sarcoptic mange in sheep starts on the face and ears. Microscopic examination of skin scrapings definitively distinguishes species. Reporting obligations vary by country for Psoroptes ovis.

No vaccines are currently available for prevention of chorioptic mange in livestock. Prevention relies entirely on antiparasitic treatment protocols, quarantine of incoming animals, and management practices that reduce mite transmission. Research into mite-specific vaccines for livestock has focused primarily on tick control (Boophilus microplus vaccine) rather than Chorioptes. For practical management purposes, the combination of treating all animals at housing entry, quarantining new stock, and maintaining environmental hygiene in winter housing facilities provides effective prevention without vaccine technology. Annual treatment at winter housing entry remains the most reliable strategy for endemic herds.

Yes — storage mite allergy is a well-documented occupational hazard for farmers handling grain, hay, and stored animal feed. Swedish farmer studies showed 37.8% IgE sensitization to storage mites in Gotland farmers. Acarus siro (grain mite), Lepidoglyphus destructor (hay mite), and Tyrophagus putrescentiae (cheese/mold mite) are present in high concentrations in agricultural stored food environments. These mites have well-characterized allergens that cause genuine occupational asthma and rhinitis through inhaled allergen sensitization. This is entirely distinct from the irritant contact reactions possible from C. bovis — farm workers with respiratory symptoms need allergy evaluation for these occupational allergens, which may be amenable to immunotherapy.

Ivermectin resistance in Chorioptes bovis has not been widely documented as a clinical problem compared to the more extensively characterized macrocyclic lactone resistance in gastrointestinal nematodes. However, reduced efficacy of ivermectin for chorioptic mange compared to sarcoptic mange has been noted in some studies, leading to recommendations for a second treatment at 2-3 weeks. Moxidectin generally demonstrates good efficacy against Chorioptes. If treatment failure is suspected — significant mite burden persisting 4-6 weeks after treatment — consult a veterinary parasitologist about alternative treatment approaches and ensure accurate diagnosis through skin scraping before attributing failure to resistance.